{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:09:44Z","timestamp":1793149784523,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Human cytomegalovirus (HCMV) is the most common virus to affect the recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT). HCMV reactivation increases the risk of secondary fungal and bacterial infections, as well as that of non-relapse mortality after allo-HSCT. This study investigates the post-transplantation reconstitution of HCMV-specific T cells and their role in the regulation of HCMV infections. Peripheral blood samples from CMV-seropositive allo-HSCT recipients (R+) and CMV-seropositive donors (D+) were collected from October 2019 to June 2021. Continuous quantification and function monitoring of CMV-specific CD4+\/CD8+T lymphocytes were performed by flow cytometry after stimulation in an HCMV-pp65 pool\n                    <jats:italic>in vitro<\/jats:italic>\n                    and intracellular cytokine staining was performed. Plasma CMV\u2013DNA was quantitatively detected by qPCR. The median age of patients (\n                    <jats:italic>n<\/jats:italic>\n                    = 131) was 34 (23\u201345) years. Post-transplantation HCMV reactivation occurred in 88 (67.2%) patients. HCMV-responsive CD4+T cells in non-HCMV reactivation patients was significantly higher than that in HCMV reactivation patients 30 days after transplantation (0.21 cells\/\u03bcL vs 0.10 cells\/\u03bcL;\n                    <jats:italic>P<\/jats:italic>\n                    = 0.005). Kaplan\u2013Meier analysis showed that the incidence of HCMV reactivation in patients with low levels of HCMV-responsive CD4+T cells (&amp;lt;0.14 cells\/\u03bcL) was significantly higher than that in patients with high levels of HCMV-responsive CD4+T cells (&amp;gt;0.14 cells\/\u03bcL) (83.9% vs 54.7%;\n                    <jats:italic>P<\/jats:italic>\n                    &amp;lt; 0.001). Patients lacking HCMV-responsive CD8+T cells (&amp;lt;2 cells\/\u03bcL) 60 days after allo-HSCT had a significantly higher risk of HCMV reactivation 100 days after transplantation (\n                    <jats:italic>HR<\/jats:italic>\n                    9.932;\n                    <jats:italic>P<\/jats:italic>\n                    = 0.005). Patient age and the mononuclear cell-infusion level were correlated with the reconstructive levels of HCMV-responsive CD8+T cells 60 days after transplantation. Poor recovery of HCMV-responsive CD4+T cells 30 days post-transplantation is closely related to the risk of HCMV reactivation. The level of HCMV-responsive CD8+T cells 60 days post-transplantation is a good predictor for late-onset HCMV reactivation, which is particularly important for outpatient monitoring and management of patients with allo-HSCT, and facilitates individualized risk stratification for HCMV reactivation.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1464096","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:05:52Z","timestamp":1741752352000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Immune reconstitution of human cytomegalovirus-specific T lymphocytes after allogeneic hematopoietic stem cell transplantation and their predictive role in reactivation"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuanqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiming","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.v29.3","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112666","article-title":"Cytomegalovirus infections after hematopoietic stem cell transplantation: current status and future immunotherapy","volume":"20","author":"Cho","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00043-19","article-title":"Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation","volume":"34","author":"Limaye","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12879-022-07298-2","article-title":"Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11908-019-0699-0","article-title":"CMV prevention and treatment in transplantation: what\u2019s new in 2019","volume":"21","author":"Stern","year":"2019","journal-title":"Curr Infect Dis Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04707-5","article-title":"Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants","volume":"101","author":"Yi","year":"2022","journal-title":"Ann Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy696","article-title":"Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials","volume":"68","author":"Chemaly","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/v14020352","article-title":"Cytomegalovirus diseases of the gastrointestinal tract","volume":"14","author":"Yeh","year":"2022","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S225465","article-title":"Protective effects of cytomegalovirus DNA copies >==1000\/mL for AML patients in complete remission after single cord blood transplantation","volume":"13","author":"Dong","year":"2020","journal-title":"Infect Drug Resist"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/imm.v172.3","article-title":"Single-cell transcriptomic and T cell antigen receptor analysis of human cytomegalovirus (hCMV)-specific memory T cells reveals effectors and pre-effectors of CD8(+)- and CD4(+)-cytotoxic T cells","volume":"172","author":"Kar","year":"2024","journal-title":"Immunology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779961","article-title":"Dissecting the landscape of activated CMV-stimulated CD4+ T cells in humans by linking single-cell RNA-seq with T-cell receptor sequencing","volume":"12","author":"Lyu","year":"2021","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.08.002","article-title":"Reconstitution of human cytomegalovirus-specific CD4+ T cells is critical for control of virus reactivation in hematopoietic stem cell transplant recipients but does not prevent organ infection","volume":"21","author":"Gabanti","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.11.038","article-title":"Impact of cytomegalovirus viral load on probability of spontaneous clearance and response to preemptive therapy in allogeneic stem cell transplantation recipients","volume":"24","author":"Camargo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.09.010","article-title":"American Society for Transplantation and Cellular Therapy Series: 4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation","volume":"27","author":"Yong","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04201-4","article-title":"Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation","volume":"99","author":"Meng","year":"2020","journal-title":"Ann Hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2022.2042686","article-title":"Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide","author":"Freyer","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21348","article-title":"Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation","volume":"92","author":"Pelak","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2004.02.017","article-title":"Analysis of antigen-specific T-cell responses with synthetic peptides\u2013what kind of peptide for which purpose","volume":"65","author":"Kiecker","year":"2004","journal-title":"Hum Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.229252","article-title":"Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation","volume":"106","author":"Wagner-Drouet","year":"2021","journal-title":"Haematologica"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01539-13","article-title":"Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo","volume":"87","author":"Reeves","year":"2013","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01206-16","article-title":"Human cytomegalovirus requires epidermal growth factor receptor signaling to enter and initiate the early steps in the establishment of latency in CD34(+) human progenitor cells","volume":"91","author":"Kim","year":"2017","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.271445","article-title":"Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation","volume":"107","author":"Massoud","year":"2022","journal-title":"Haematologica"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-234096","article-title":"Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update","volume":"115","author":"Seggewiss","year":"2010","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/ejh.2018.101.issue-1","article-title":"Rapid reconstitution of CMV-specific T-cells after stem-cell transplantation","volume":"101","author":"Widmann","year":"2018","journal-title":"Eur J Haematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.265","article-title":"Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation","volume":"50","author":"Tey","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s40506-021-00253-w","article-title":"CMV infection in hematopoietic stem cell transplantation: prevention and treatment strategies","volume":"13","author":"Jakharia","year":"2021","journal-title":"Curr Treat Options Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.01.018","article-title":"Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation","volume":"20","author":"Lugthart","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v10.23","article-title":"Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single-center retrospective study","volume":"10","author":"Lv","year":"2021","journal-title":"Cancer Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1464096\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:05:55Z","timestamp":1741752355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1464096\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2025.1464096"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1464096","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"article-number":"1464096"}}